August 16, 2022
New research should give expectant mothers some peace of mind.
August 03, 2022
Humira may face competition from multiple generics next year, but an octet of other biologics may also see competition this decade.
June 22, 2022
Six are currently on the market and more are in the pipeline.
June 16, 2022
The biosimilar has a list price 40% less than its reference product.
June 15, 2022
Infliximab biosimilars have been available since 2016.
June 03, 2022
The average sales price (ASP) for biosimilars of Neupogen has declined more than 50% since these lower cost agents began to be sold in 2015.
June 01, 2022
Pharmacy benefit managers can help health plans understand when to best leverage and align to biosimilars and other cost-effective treatments.
May 19, 2022
Circle 2023 on your calendar. That's when as many as 11 biosimilars to Humira are headed for the US market.
May 13, 2022
Efforts to improve education on biosimilars are a start, but payer policies must catch up to ensure real change.
March 19, 2022
Gaps exist in knowledge about interchangeability and substitutions.
